An innovative alternative for cervical cancer screening by means of HPV DNA (HPV DNA) self-collection. do not need to trestle
Roche Diagnostics (Thailand) Co., Ltd., led by Mr. Pichetpong Srisuwankul (2nd from left), Managing Director in collaboration with the National Cancer Institute Health Security Office (NHSO) and Chonburi Cancer Hospital Organize an online academic forum on the topic “A woman must know! New alternative for cervical cancer screening with self-collected HPV DNA method Do not have to trestle “to educate. and information on the importance of HPV DNA screening for cervical cancer for people, especially targeted women, who can now collect samples by themselves in the hospital. Hoping to add new options for testing Reduce concerns such as fear of pain, embarrassment from doctors, as well as worries regarding expenses Confirming health insurance eligibility to cover examinations, treatments, assuring the concept of detection (HPV) early can reduce the risk of cervical cancer and death. Dr. Piyawat Laohutanon (left), Director of Chonburi Cancer Hospital and a specialist in gynecological oncology, Dr. Suleeporn Sangkrachang (2nd from right), Deputy Director of System Development health National Cancer Institute and Dr. Attaporn Limpanyalert (right), Deputy Secretary-General of the National Health Security Office (NHSO) recently joined the discussion via the company’s YouTube Live channel.
